TITLE

NT-proBNP-guided and clinically guided treatment reduced short-term but not long-term mortality in chronic HF

AUTHOR(S)
Karuppiah, Sabesan; Wilson, Stephen A.; Narumoto, Keiichiro
PUB. DATE
April 2010
SOURCE
ACP Journal Club;4/20/2010, Vol. 152 Issue 4, p3
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article presents information on the research study undertaken to find if the N-terminal-pro-B-type natriuretic peptide (NT-proBNP)-guided or clinically guided (CG) treatment is more effective in chronic heart failure (HF) patients than the usual care (UC). 364 patients underwent the randomized controlled trial. The findings show that both NTNT-proBNP-guided and clinically guided treatment reduce mortality than usual primary care in the short-term but not so in the long-term.
ACCESSION #
50294722

 

Related Articles

  • Cardiac Resynchronization in Mild Heart Failure: All Issues Resolved? Maass, Alexander // Cardiovascular Drugs & Therapy;Aug2011, Vol. 25 Issue 4, p281 

    The author examines the role of cardiac resynchronization therapy (CRT) in patients with mild heart failure. He cites several studies showing how CRT improves the symptoms. The author points out the importance of optimal delivery of CRT when performing randomized controlled trials. The author...

  • The Effect of a Primary Care Practice--Based Depression Intervention on Mortality in Older Adults. Gallo, Joseph J.; Bogner, Hillary R.; Morales, Knashawn H.; Post, Edward P.; Lin, Julia Y.; Bruce, Martha L. // Annals of Internal Medicine;5/15/2007, Vol. 146 Issue 10, p689 

    Background: Few studies have tested the effects of a depression intervention on the risk for death associated with depression. Objective: To test whether an intervention to improve depression care can modify the risk for death. Design: Practice-based, randomized, controlled trial. Setting: 20...

  • Opponent's comment. Georgianos, Panagiotis I.; Sarafidis, Pantelis A. // Nephrology Dialysis Transplantation;Jan2015, Vol. 30 Issue 1, p27 

    No abstract available.

  • Home care in heart failure: towards an integrated care model. Jaarsma, Tiny; Luttik, Marie Louise // European Journal of Heart Failure;Aug2011, Vol. 13 Issue 8, p823 

    No abstract available.

  • The Heart failure and Optimal Outcomes from Pharmacy Study (HOOPS): rationale, design, and baseline characteristics. Lowrie, Richard; Mair, Frances S.; Greenlaw, Nicola; Forsyth, Paul; McConnachie, Alex; Richardson, Janice; Khan, Nina; Morrison, Deborah; Messow, Claudia-Martina; Rae, Brian; McMurray, John J.V. // European Journal of Heart Failure;Aug2011, Vol. 13 Issue 8, p917 

    Aims The effect on mortality and morbidity of pharmacist-led intervention to optimize pharmacological therapy in patients with systolic heart failure (HF) has not been tested in a large-scale, long-term, clinical trial. Methods We describe the rationale and design of a UK, primary care-based,...

  • Current treatments for acute heart failure: focus on serelaxin. Bennett, Robert G. // Research Reports in Clinical Cardiology;2014, Vol. 5, p169 

    Acute heart failure remains an enormous health concern worldwide, and is a major cause of death and hospitalization. In spite of this, the treatment strategies for acute heart failure have remained largely unchanged for the past 2 decades. Several large randomized, placebo- controlled clinical...

  • Cardiac Resynchronization Therapy in Patients with Mild Heart Failure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Tu, Ronghui; Zhong, Guoqiang; Zeng, Zhiyu; Wu, Weifeng; Wu, Hai; Cao, Xiaoli; Aung, Lynn // Cardiovascular Drugs & Therapy;Aug2011, Vol. 25 Issue 4, p331 

    Objective: This review aims at updating the results of cardiac resynchronization therapy (CRT) in mild heart failure patients, and investigating whether CRT can prevent or reverse heart failure progression in an earlier stage. Methods: Randomized controlled trials of CRT in patients with New...

  • HEART FAILURE WITH PRESERVED EJECTION FRACTION: THERAPEUTIC ENIGMA. CHIRCU, CRISTINA MIHAELA; MANIȚIU, IOAN; TEODORU, MINODORA; BEBEȘELEA, ANDRA; CǍLUȚIU, NICOLETA // Acta Medica Transilvanica;dec2014, Vol. 19 Issue 4, p229 

    Heart failure with preserved ejection fraction (HFPEF) is increasing in prevalence with the aging of the population, and morbidity and mortality rates are comparable to that of heart failure with reduced ejection fraction (HFREF). Recent literature focusing on the pathophysiology underlying this...

  • Trimetazidine: a meta-analysis of randomised controlled trials in heart failure. Dengfeng Gao; Ning Ning; Xiaolin Niu; Guanghua Hao; Zhe Meng // Heart;Feb2011, Vol. 97 Issue 4, p278 

    Objective To explore whether trimetazidine could improve symptoms, cardiac functions and clinical outcomes in patients with heart failure (HF). Methods A systematic literature search was conducted to identify randomised controlled trials (RCT) of trimetazidine for HF between 1966 and May 2010 in...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics